SEBASTIAN M. SCHELLONG

机构：Städtisches Klinikum Dresden · ORCID：0000-0001-9344-3799

发表论文 411 篇 · 总被引 19237 次 · h-index 56

代表论文

• Global Variations in Heart Failure Etiology, Management, and Outcomes (2023 · JAMA · 被引 169)
• Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors (2023 · Circulation · 被引 160)
• A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction (2022 · Circulation · 被引 157)
• Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial (2025 · The Lancet · 被引 84)
• Clinical Presentation and Short- and Long-term Outcomes in Patients With Isolated Distal Deep Vein Thrombosis vs Proximal Deep Vein Thrombosis in the RIETE Registry (2022 · JAMA Cardiology · 被引 62)
• Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial (2022 · The Lancet Haematology · 被引 61)